Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
Public ClinicalTrials.gov record NCT02612922. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Randomized Double-Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Trial to evaluate efficacy and safety of nitazoxanide (NTZ) in the treatment of acute uncomplicated influenza.
Study identification
- NCT ID
- NCT02612922
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 325 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2015 (Type not available)
- Primary completion
- Sep 4, 2016 (Actual)
- Completion
- Sep 4, 2016 (Actual)
- Last update posted
- Apr 4, 2018
2015 – 2016
United States locations
- U.S. sites
- 17
- U.S. states
- 8
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Influence Study Site | Hot Springs | Arkansas | 71913 | — |
| Influence Study Site | Anaheim | California | 92805 | — |
| Influence Study Site | Fresno | California | 93702 | — |
| Influence Study Site | Lomita | California | 90717 | — |
| Influence Study Site | Kissimmee | Florida | 34744 | — |
| Influence Study Site | Lauderdale Lakes | Florida | 33319 | — |
| Influence Study Site | Saint Cloud | Florida | 34769 | — |
| Influence Study Site | Columbus | Georgia | 31904 | — |
| Influence Study Site | Savannah | Georgia | 31401 | — |
| Influence Study Site | Lansdale | Pennsylvania | 19446 | — |
| Influence Study Site | Rapid City | South Dakota | 57702 | — |
| Influence Study Site | Jackson | Tennessee | 38305 | — |
| Influence Study Site | Austin | Texas | 78735 | — |
| Influence Study Site | Houston | Texas | 77058 | — |
| Influence Study Site | Pharr | Texas | 78577 | — |
| Influence Study Site | Plano | Texas | 75024 | — |
| Influence Study Site | Waco | Texas | 76710 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02612922, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 4, 2018 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02612922 live on ClinicalTrials.gov.